This page shows the latest respiratory syncytial virus news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca/Sanofi’s monoclonal antibody has been recommended by a US Food and Drug Administration’s (FDA) panel of experts for the prevention of respiratory syncytial virus (RSV) lower respiratory tract ... RSV is a common contagious virus
GSK’s respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) for the prevention of RSV-caused lower respiratory tract disease (LRTD) in adults aged 60 years ... RSV is a common contagious virus characterised by
Pfizer's respiratory syncytial virus (RSV) vaccine has been approved by the US Food and Drug Administration (FDA) for the prevention of RSV-caused lower respiratory tract disease (LRTD) in adults ... RSV is a common contagious virus characterised by
Pfizer’s respiratory syncytial virus (RSV) maternal vaccine candidate has been recommended for approval by a US Food and Drug Administration (FDA) panel of experts. ... Although most people recover within a week or two, the virus can potentially cause
GSK’s respiratory syncytial virus (RSV) vaccine has been approved in the US for the prevention of RSV-caused lower respiratory tract disease (LRTD) in adults aged 60 years and older. ... RSV is a common contagious virus characterised by several mild,
GSK’s respiratory syncytial virus (RSV) vaccine candidate has been recommended by the European Medicines Agency’s human medicines committee for the prevention of RSV-caused lower respiratory tract disease (LRTD) ... There are currently no vaccines
More from news
Approximately 19 fully matching, plus 55 partially matching documents found.
Up to that point, the drug was being developed to treat respiratory viral infections in patients with COPD who are at risk of experiencing exacerbations, which can be deadly and typically ... challenge study, in this case respiratory syncytial virus (RSV)
In the absence of a knockout antiviral, researchers are trying to mitigate harmful effects of the virus. ... Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus.
has encouraged people to knit hats and blankets for babies to alert people to respiratory syncytial virus.
In order to focus its respiratory resources on products such as Symbicort and benralizumab, AstraZeneca has agreed that its product Tudorza (marketed for COPD) and Duaklir (in phase III for COPD) ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur.
Alios has an oral anti-viral in phase 2 for treatment of infant respiratory syncytial virus (RSV) which complements J&J's early stage programmes in RSV.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
During the last 12 months Mucosis has completed a clinical proof of concept study in human influenza for Mimopath and advanced respiratory syncytial virus (RSV) candidate SynGEM into pre-clinical studies.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...